Brief: Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment To License And Collaboration Agreement
BRIEF-Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment To License And Collaboration Agreement Oct 6 (Reuters) - Regeneron Pharmaceuticals, Inc. REGN.O:
REGENERON PHARMACEUTICALS - SANOFI ENTER SIXTH AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT - SEC FILING
REGENERON PHARMACEUTICALS - IPR&D CHARGE EXPECTED TO REDUCE Q3 2026 GAAP AND NON-GAAP EPS BY $0.18 - SEC FILING
Source text: [ID:n0001104659-26-113895]
Further company coverage: REGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle